Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating ...
However, some mutations give cells a growth advantage, meaning they can clone cells with the same mutations. These patches have the potential to become the earliest stages of cancer. For the study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback